Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexgel (NXGL) EBITDA (2018 - 2025)

Nexgel (NXGL) has disclosed EBITDA for 8 consecutive years, with -$725000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA rose 7.99% year-over-year to -$725000.0, compared with a TTM value of -$3.0 million through Sep 2025, up 24.24%, and an annual FY2024 reading of -$3.6 million, down 2.21% over the prior year.
  • EBITDA was -$725000.0 for Q3 2025 at Nexgel, down from -$636000.0 in the prior quarter.
  • Across five years, EBITDA topped out at -$520000.0 in Q1 2021 and bottomed at -$1.2 million in Q4 2023.
  • Average EBITDA over 5 years is -$794052.6, with a median of -$781000.0 recorded in 2022.
  • The sharpest move saw EBITDA plummeted 70.0% in 2022, then skyrocketed 40.98% in 2023.
  • Year by year, EBITDA stood at -$887000.0 in 2021, then grew by 11.95% to -$781000.0 in 2022, then crashed by 56.08% to -$1.2 million in 2023, then skyrocketed by 31.01% to -$841000.0 in 2024, then increased by 13.79% to -$725000.0 in 2025.
  • Business Quant data shows EBITDA for NXGL at -$725000.0 in Q3 2025, -$636000.0 in Q2 2025, and -$777000.0 in Q1 2025.